MIF and chronic kidney disease: Meanwhile, the stable urinary values of MIF in CKD stages 3–5 vs. stages 1–2, as well as their negative correlation with eGFR, suggest a suppression of pro-inflammatory activity in response to the progression of fibrosis, which is characteristic of the advanced stages of CKD.